arrow
J

Jeffrey F. Ohren

Pfizer
H指数:22
被引数:2,101

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Aminopyrazole Carboxamide Bruton's Tyrosine Kinase Inhibitors. Irreversible to Reversible Covalent Reactive Group Tuning
2018-12-0335
OAAI
Selectively targeting an inactive conformation of interleukin-2-inducible T-cell kinase by allosteric inhibitors

变构抑制剂选择性靶向interleukin-2-inducible T细胞激酶的非活性构象

2014-05-1319
PREAI
Discovery of a Series of Imidazo[4,5-b]pyridines with Dual Activity at Angiotensin II Type 1 Receptor and Peroxisome Proliferator-Activated Receptor-γ
2011-05-2653
PREAI
Entrainment of disrupted circadian behavior through inhibition of casein kinase 1 (CK1) enzymes
2010-08-09197
OAAI
Selective Inhibition of Casein Kinase 1ε Minimally Alters Circadian Clock Period
2009-08-01156
PREAI
Effects of modifications of the linker in a series of phenylpropanoic acid derivatives:: Synthesis, evaluation as PPARα/γ dual agonists, and X-ray crystallographic studies
2008-05-0126
PRE
Rational protein engineering in action:: The first crystal structure of a phenylalanine tRNA synthetase from Staphylococcus haemolyticus

合理的蛋白质工程在起作用:: 溶血葡萄球菌苯丙氨酸tRNA合成酶的第一个晶体结构

2008-04-0115
PREAI
4-anilino-5-carboxamido-2-pyridone derivatives as noncompetitive inhibitors of mitogen-activated protein kinase kinase
2007-09-1957
PREAI
Structures of human MAP kinase kinase 1 (MEK1) and MEK2 describe novel noncompetitive kinase inhibition

人MAP激酶激酶1 (MEK1) 和MEK2的结构描述了新的非竞争性激酶抑制

2004-11-14600
PREAI